skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8847

Cholesterol-lowering phytosterols: factors affecting their use and efficacy

Review

(2606) Views  (1617) Full article downloads

Authors: Timothy P Carr, Mark M Ash, Andrew W Brown

Published Date July 2010 Volume 2010:2 Pages 59 - 72
DOI: http://dx.doi.org/10.2147/NDS.S10974

Timothy P Carr, Mark M Ash, Andrew W Brown
Department of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE, USA

Abstract: Phytosterols are essential components of plant cells and therefore naturally ­present in the human diet. When used therapeutically, phytosterols can significantly lower serum cholesterol concentrations. Meta-analyses of clinical trials indicate about 10% reduction of low-density lipoprotein cholesterol when phytosterols are consumed at the recommended dose of 2 g/d. Thus, phytosterols can be an important part of an overall dietary strategy to manage cholesterol levels, particularly for patients who cannot tolerate cholesterol-lowering drugs. Although other health benefits have been attributed to phytosterols, including anti-inflammatory, anticancer, and immune regulatory effects, this review will focus on the therapeutic use of phytosterols related to serum cholesterol, their mechanisms of action, and the various types of phytosterols available to consumers.

Keywords: sterols, stanols phytosterols, cholesterol






Readers of this article also read:

Berberine: metabolic and cardiovascular effects in preclinical and clinical trials
Potential renovascular hypertension, space missions, and the role of magnesium
Polyphenols as dietary supplements: A double-edged sword
Critical appraisal of the role of glucosamine and chondroitin in the management of osteoarthritis of the knee
Ego mechanisms of defense are associated with patients’ preference of treatment modality independent of psychological distress in end-stage renal disease
Can a gentamicin-specific chart reduce neonatal medication errors?
Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology
Nephroprotective action of glycosaminoglycans: why the pharmacological properties of sulodexide might be reconsidered
Dashboards in neonatology
Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University